Summit Therapeutics (SMMT) Other Non Operating Income (2019 - 2023)

Summit Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $419000.0 for Q1 2023.

• Quarterly Other Non Operating Income changed N/A year-over-year to $419000.0 in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $419000.0 (changed N/A YoY) and the FY2023 annual result came in at $419000.0, changed N/A from the prior year.
• Other Non Operating Income was $419000.0 for Q1 2023 at Summit Therapeutics, up from $416000.0 in the prior quarter.
• Across five years, Other Non Operating Income topped out at $419000.0 in Q1 2023 and bottomed at -$75000.0 in Q3 2019.
• A 3-year average of $253333.3 and a median of $416000.0 in 2020 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 654.67% in 2020, while the deepest fall reached 654.67% in 2020.
• Summit Therapeutics' Other Non Operating Income stood at -$75000.0 in 2019, then surged by 654.67% to $416000.0 in 2020, then advanced by 0.72% to $419000.0 in 2023.
• Business Quant data shows SMMT's Other Non Operating Income at $419000.0 in Q1 2023, $416000.0 in Q3 2020, and -$75000.0 in Q3 2019.